Ikena Oncology, Inc. (IKNA)
NASDAQ: IKNA · Real-Time Price · USD
1.180
-0.030 (-2.48%)
Apr 25, 2025, 12:35 PM EDT - Market open
Ikena Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 39.39 | 119.89 | 59.92 | 232.22 | 162.49 | Upgrade
|
| Short-Term Investments | 84.99 | 55.57 | 97.03 | - | - | Upgrade
|
| Cash & Short-Term Investments | 124.39 | 175.47 | 156.95 | 232.22 | 162.49 | Upgrade
|
| Cash Growth | -29.11% | 11.80% | -32.41% | 42.91% | 97.96% | Upgrade
|
| Prepaid Expenses | 2.78 | 3.2 | 2.1 | 3.67 | 1.94 | Upgrade
|
| Other Current Assets | - | - | 0.96 | 0.63 | 1.54 | Upgrade
|
| Total Current Assets | 127.17 | 178.66 | 160.01 | 236.52 | 165.97 | Upgrade
|
| Property, Plant & Equipment | 4.23 | 8.02 | 8.46 | 8.98 | 1.56 | Upgrade
|
| Other Long-Term Assets | 10.11 | 5.41 | 3.79 | 2.39 | 0.87 | Upgrade
|
| Total Assets | 141.51 | 192.09 | 172.26 | 247.88 | 168.4 | Upgrade
|
| Accounts Payable | 0.9 | 2.07 | 2.09 | 2.38 | 2.12 | Upgrade
|
| Accrued Expenses | 6.07 | 8.5 | 8.22 | 5.83 | 5.02 | Upgrade
|
| Current Portion of Leases | 3.78 | 3.56 | 1.91 | 1.85 | 0.19 | Upgrade
|
| Current Unearned Revenue | - | - | 9.16 | 17.1 | 20.62 | Upgrade
|
| Other Current Liabilities | 0.02 | 0.09 | 0.12 | 0.03 | 0.38 | Upgrade
|
| Total Current Liabilities | 10.78 | 14.21 | 21.5 | 27.19 | 28.33 | Upgrade
|
| Long-Term Leases | 3.74 | 7.18 | 3.79 | 5.14 | - | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | 7.68 | 35.14 | Upgrade
|
| Other Long-Term Liabilities | 1.06 | 0.95 | - | - | - | Upgrade
|
| Total Liabilities | 15.58 | 22.34 | 25.29 | 40 | 63.47 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.04 | 0.04 | 0 | Upgrade
|
| Additional Paid-In Capital | 457.44 | 452.14 | 361.92 | 353.3 | 10.29 | Upgrade
|
| Retained Earnings | -331.62 | -282.39 | -214.22 | -145.45 | -111.34 | Upgrade
|
| Comprehensive Income & Other | 0.07 | -0.05 | -0.76 | - | - | Upgrade
|
| Total Common Equity | 125.93 | 169.76 | 146.97 | 207.88 | -101.05 | Upgrade
|
| Shareholders' Equity | 125.93 | 169.76 | 146.97 | 207.88 | 104.93 | Upgrade
|
| Total Liabilities & Equity | 141.51 | 192.09 | 172.26 | 247.88 | 168.4 | Upgrade
|
| Total Debt | 7.52 | 10.74 | 5.69 | 6.99 | 0.19 | Upgrade
|
| Net Cash (Debt) | 116.87 | 164.73 | 151.25 | 225.23 | 162.31 | Upgrade
|
| Net Cash Growth | -29.05% | 8.91% | -32.84% | 38.77% | 97.73% | Upgrade
|
| Net Cash Per Share | 2.42 | 3.95 | 4.18 | 8.05 | 58.69 | Upgrade
|
| Filing Date Shares Outstanding | 48.26 | 48.26 | 36.26 | 36.11 | 3.14 | Upgrade
|
| Total Common Shares Outstanding | 48.26 | 48.26 | 36.26 | 35.98 | 3.1 | Upgrade
|
| Working Capital | 116.39 | 164.46 | 138.51 | 209.33 | 137.64 | Upgrade
|
| Book Value Per Share | 2.61 | 3.52 | 4.05 | 5.78 | -32.63 | Upgrade
|
| Tangible Book Value | 125.93 | 169.76 | 146.97 | 207.88 | -101.05 | Upgrade
|
| Tangible Book Value Per Share | 2.61 | 3.52 | 4.05 | 5.78 | -32.63 | Upgrade
|
| Machinery | 0.82 | 3.85 | 3.81 | 2.59 | 1.14 | Upgrade
|
| Leasehold Improvements | 1.22 | 1.22 | 1.22 | 0.92 | 0.94 | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.